(Q43557028)

24 November 2017

title

Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial (English)

1 reference

24 November 2017

1 reference

1

Edward Giovannucci

1 reference

24 November 2017

publication date

15 May 2011

1 reference

24 November 2017

published in

Cancer Causes & Control

1 reference

24 November 2017

volume

22

1 reference

24 November 2017

issue

7

1 reference

24 November 2017

page(s)

1055-1059

1 reference

https://scigraph.springernature.com/pub.10.1007/s10552-011-9776-x

24 November 2017

exact match

0 references

cites work

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

A prospective study of lycopene and tomato product intake and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Intake of carotenoids and retinol in relation to risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Diet and cancer of the prostate: a case-control study in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Cohort study of diet, lifestyle, and prostate cancer in Adventist men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

How Well Does the Gleason Score Predict Prostate Cancer Death? A 20-Year Followup of a Population Based Cohort in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10552-011-9776-X

10.1007/S10552-011-9776-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

1011033445

0 references

1 reference